PDCD1 and cancer: Biomarkers such as PD-1 (programmed cell death 1 or PDCD1), PD-L1 (programmed cell death 1 ligand 1 or CD274 molecule), and CD8, in addition to microsatellite instability (MSI), have been recognized as valuable markers for indicating immunotherapy in other types of cancer [19,20].